BMY logo

Bristol-Myers Squibb (BMY) EBIT

annual EBIT:

-$6.43B-$16.04B(-166.96%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BMY annual earnings before interest & taxes is -$6.43 billion, with the most recent change of -$16.04 billion (-166.96%) on December 31, 2024.
  • During the last 3 years, BMY annual EBIT has fallen by -$15.86 billion (-168.19%).
  • BMY annual EBIT is now -166.96% below its all-time high of $9.61 billion, reached on December 31, 2023.

Performance

BMY EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

quarterly EBIT:

$3.46B+$2.79B(+416.39%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BMY quarterly earnings before interest & taxes is $3.46 billion, with the most recent change of +$2.79 billion (+416.39%) on March 31, 2025.
  • Over the past year, BMY quarterly EBIT has increased by +$14.56 billion (+131.24%).
  • BMY quarterly EBIT is now at all-time high.

Performance

BMY quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

TTM EBIT:

$8.12B+$14.56B(+226.31%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BMY TTM earnings before interest & taxes is $8.12 billion, with the most recent change of +$14.56 billion (+226.31%) on March 31, 2025.
  • Over the past year, BMY TTM EBIT has increased by +$12.67 billion (+278.82%).
  • BMY TTM EBIT is now -18.68% below its all-time high of $9.99 billion, reached on March 31, 2023.

Performance

BMY TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BMY EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-167.0%+131.2%+278.8%
3 y3 years-168.2%+72.1%-5.1%
5 y5 years-214.2%+5874.1%+121.7%

BMY EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-167.0%at lowat high+131.2%-18.7%+226.3%
5 y5-year-167.0%at lowat high+131.2%-18.7%+226.3%
alltimeall time-167.0%at lowat high+131.2%-18.7%+226.3%

BMY EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$3.46B(+416.4%)
$8.12B(-226.3%)
Dec 2024
-$6.43B(-167.0%)
$671.00M(-69.2%)
-$6.43B(+25.8%)
Sep 2024
-
$2.18B(+20.7%)
-$5.11B(+4.8%)
Jun 2024
-
$1.81B(-116.3%)
-$4.88B(+7.4%)
Mar 2024
-
-$11.09B(-657.3%)
-$4.54B(-147.3%)
Dec 2023
$9.61B(+7.4%)
$1.99B(-17.7%)
$9.61B(-1.7%)
Sep 2023
-
$2.42B(+12.9%)
$9.77B(-0.9%)
Jun 2023
-
$2.14B(-30.0%)
$9.86B(-1.3%)
Mar 2023
-
$3.06B(+42.0%)
$9.99B(+11.7%)
Dec 2022
$8.95B(-5.2%)
$2.15B(-14.2%)
$8.95B(-0.3%)
Sep 2022
-
$2.51B(+10.4%)
$8.97B(+0.3%)
Jun 2022
-
$2.27B(+12.8%)
$8.95B(+4.5%)
Mar 2022
-
$2.01B(-7.7%)
$8.56B(-9.2%)
Dec 2021
$9.43B(-273.0%)
$2.18B(-12.2%)
$9.43B(-431.5%)
Sep 2021
-
$2.48B(+32.0%)
-$2.85B(+4.3%)
Jun 2021
-
$1.88B(-34.7%)
-$2.73B(+3.8%)
Mar 2021
-
$2.88B(-128.6%)
-$2.63B(-51.8%)
Dec 2020
-$5.45B(-196.8%)
-$10.10B(-487.9%)
-$5.45B(-213.7%)
Sep 2020
-
$2.60B(+31.2%)
$4.79B(+27.9%)
Jun 2020
-
$1.98B(+3320.7%)
$3.75B(+2.3%)
Mar 2020
-
$58.00M(-61.3%)
$3.67B(-34.9%)
Dec 2019
$5.63B(-8.5%)
$150.00M(-90.4%)
$5.63B(-19.9%)
Sep 2019
-
$1.56B(-18.0%)
$7.03B(-8.5%)
Jun 2019
-
$1.90B(-6.2%)
$7.69B(+21.1%)
Mar 2019
-
$2.02B(+30.3%)
$6.35B(+3.2%)
Dec 2018
$6.15B(+15.5%)
$1.55B(-29.8%)
$6.15B(+15.0%)
Sep 2018
-
$2.21B(+293.4%)
$5.35B(+22.4%)
Jun 2018
-
$562.00M(-69.2%)
$4.37B(-15.2%)
Mar 2018
-
$1.82B(+143.7%)
$5.15B(-3.3%)
Dec 2017
$5.33B(-12.4%)
$749.00M(-39.2%)
$5.33B(-6.6%)
Sep 2017
-
$1.23B(-8.6%)
$5.70B(-6.1%)
Jun 2017
-
$1.35B(-32.6%)
$6.07B(-4.9%)
Mar 2017
-
$2.00B(+77.6%)
$6.38B(+5.0%)
Dec 2016
$6.08B(+169.0%)
$1.13B(-29.7%)
$6.08B(+32.5%)
Sep 2016
-
$1.60B(-3.4%)
$4.59B(+14.3%)
Jun 2016
-
$1.66B(-2.4%)
$4.02B(+63.3%)
Mar 2016
-
$1.70B(-562.7%)
$2.46B(+8.8%)
Dec 2015
$2.26B(-12.5%)
-$367.00M(-135.7%)
$2.26B(-13.7%)
Sep 2015
-
$1.03B(+917.8%)
$2.62B(-1.1%)
Jun 2015
-
$101.00M(-93.3%)
$2.65B(-12.9%)
Mar 2015
-
$1.50B(<-9900.0%)
$3.04B(+17.8%)
Dec 2014
$2.58B(-16.4%)
-$7.00M(-100.7%)
$2.58B(-26.4%)
Sep 2014
-
$1.06B(+114.2%)
$3.51B(+5.8%)
Jun 2014
-
$494.00M(-52.5%)
$3.32B(-2.5%)
Mar 2014
-
$1.04B(+12.7%)
$3.40B(+10.2%)
Dec 2013
$3.09B(+22.5%)
$922.00M(+6.7%)
$3.09B(+13.1%)
Sep 2013
-
$864.00M(+49.0%)
$2.73B(+315.8%)
Jun 2013
-
$580.00M(-19.9%)
$657.00M(-44.2%)
Mar 2013
-
$724.00M(+28.4%)
$1.18B(-53.3%)
Dec 2012
$2.52B(-64.6%)
$564.00M(-146.6%)
$2.52B(-29.8%)
Sep 2012
-
-$1.21B(-210.1%)
$3.59B(-46.2%)
Jun 2012
-
$1.10B(-46.8%)
$6.67B(-9.8%)
Mar 2012
-
$2.07B(+26.5%)
$7.40B(+3.8%)
Dec 2011
$7.13B(+14.6%)
$1.64B(-12.5%)
$7.13B(+2.6%)
Sep 2011
-
$1.87B(+2.6%)
$6.95B(+3.2%)
Jun 2011
-
$1.82B(+1.3%)
$6.73B(+3.0%)
Mar 2011
-
$1.80B(+23.6%)
$6.53B(+5.0%)
Dec 2010
$6.22B(+7.4%)
$1.46B(-11.9%)
$6.22B(+1.5%)
Sep 2010
-
$1.65B(+1.7%)
$6.12B(+0.7%)
Jun 2010
-
$1.62B(+9.4%)
$6.08B(+1.0%)
Mar 2010
-
$1.49B(+9.0%)
$6.02B(+4.1%)
Dec 2009
$5.79B(+13.8%)
$1.36B(-15.4%)
$5.79B(-4.9%)
Sep 2009
-
$1.61B(+3.1%)
$6.08B(+7.0%)
Jun 2009
-
$1.56B(+25.4%)
$5.69B(+5.2%)
Mar 2009
-
$1.25B(-25.0%)
$5.41B(-0.6%)
Dec 2008
$5.09B(+44.2%)
$1.66B(+36.7%)
$5.44B(+11.7%)
Sep 2008
-
$1.22B(-5.4%)
$4.87B(+7.5%)
Jun 2008
-
$1.28B(+0.4%)
$4.54B(+10.6%)
Mar 2008
-
$1.28B(+17.1%)
$4.10B(+13.7%)
Dec 2007
$3.53B(+47.9%)
$1.09B(+24.5%)
$3.61B(+44.6%)
Sep 2007
-
$878.00M(+3.2%)
$2.50B(+20.2%)
Jun 2007
-
$851.00M(+8.4%)
$2.08B(-7.9%)
Mar 2007
-
$785.00M(-4231.6%)
$2.25B(-5.5%)
Dec 2006
$2.39B
-$19.00M(-104.1%)
$2.39B(-21.2%)
Sep 2006
-
$458.00M(-55.5%)
$3.03B(-14.7%)
Jun 2006
-
$1.03B(+12.3%)
$3.55B(-2.6%)
DateAnnualQuarterlyTTM
Mar 2006
-
$917.00M(+47.4%)
$3.64B(-2.5%)
Dec 2005
$3.74B(-16.3%)
$622.00M(-36.5%)
$3.74B(-9.2%)
Sep 2005
-
$980.00M(-12.8%)
$4.12B(-4.5%)
Jun 2005
-
$1.12B(+11.2%)
$4.31B(-0.5%)
Mar 2005
-
$1.01B(+1.0%)
$4.33B(-3.0%)
Dec 2004
$4.46B(-9.5%)
$1.00B(-14.6%)
$4.46B(-3.4%)
Sep 2004
-
$1.17B(+2.2%)
$4.62B(-4.6%)
Jun 2004
-
$1.15B(+0.3%)
$4.84B(-2.1%)
Mar 2004
-
$1.14B(-1.1%)
$4.95B(+0.3%)
Dec 2003
$4.93B(+20.3%)
$1.16B(-17.1%)
$4.93B(+10.5%)
Sep 2003
-
$1.40B(+11.4%)
$4.46B(+7.7%)
Jun 2003
-
$1.25B(+10.9%)
$4.14B(+10.7%)
Mar 2003
-
$1.13B(+64.1%)
$3.74B(-8.7%)
Dec 2002
$4.10B(-20.5%)
$688.00M(-36.0%)
$4.10B(-4.6%)
Sep 2002
-
$1.07B(+26.2%)
$4.30B(-9.2%)
Jun 2002
-
$852.00M(-42.7%)
$4.74B(-11.7%)
Mar 2002
-
$1.49B(+67.7%)
$5.36B(-2.3%)
Dec 2001
$5.16B(-13.8%)
$886.00M(-41.4%)
$5.49B(-11.6%)
Sep 2001
-
$1.51B(+2.4%)
$6.21B(-0.2%)
Jun 2001
-
$1.48B(-8.3%)
$6.22B(-0.4%)
Mar 2001
-
$1.61B(+0.2%)
$6.24B(+1.3%)
Dec 2000
$5.99B(+14.3%)
$1.61B(+5.2%)
$6.16B(+3.7%)
Sep 2000
-
$1.53B(+1.9%)
$5.95B(+3.2%)
Jun 2000
-
$1.50B(-2.0%)
$5.76B(+3.2%)
Mar 2000
-
$1.53B(+10.2%)
$5.58B(+1.0%)
Dec 1999
$5.24B(+17.6%)
$1.39B(+3.5%)
$5.53B(+15.3%)
Sep 1999
-
$1.34B(+1.8%)
$4.79B(-0.1%)
Jun 1999
-
$1.32B(-10.7%)
$4.79B(+3.3%)
Mar 1999
-
$1.48B(+125.7%)
$4.64B(+4.1%)
Dec 1998
$4.46B(+0.4%)
$654.00M(-51.4%)
$4.46B(-8.7%)
Sep 1998
-
$1.35B(+15.6%)
$4.88B(+3.2%)
Jun 1998
-
$1.16B(-9.9%)
$4.73B(+2.9%)
Mar 1998
-
$1.29B(+20.0%)
$4.60B(+3.6%)
Dec 1997
$4.44B(+12.3%)
$1.08B(-9.9%)
$4.44B(+3.0%)
Sep 1997
-
$1.20B(+15.9%)
$4.31B(+3.3%)
Jun 1997
-
$1.03B(-8.9%)
$4.17B(+2.7%)
Mar 1997
-
$1.13B(+19.5%)
$4.06B(+2.8%)
Dec 1996
$3.95B(+9.3%)
$948.00M(-10.6%)
$3.95B(+2.2%)
Sep 1996
-
$1.06B(+14.8%)
$3.87B(+2.7%)
Jun 1996
-
$923.00M(-9.7%)
$3.77B(+1.6%)
Mar 1996
-
$1.02B(+18.4%)
$3.71B(+2.5%)
Dec 1995
$3.62B(+12.2%)
$863.00M(-9.9%)
$3.62B(+3.3%)
Sep 1995
-
$958.00M(+11.1%)
$3.50B(+2.5%)
Jun 1995
-
$862.00M(-7.5%)
$3.42B(+2.7%)
Mar 1995
-
$932.00M(+24.6%)
$3.33B(+3.2%)
Dec 1994
$3.22B(+34.0%)
$748.00M(-14.4%)
$3.22B(+25.3%)
Sep 1994
-
$874.00M(+13.2%)
$2.57B(+2.0%)
Jun 1994
-
$772.00M(-6.8%)
$2.52B(+2.8%)
Mar 1994
-
$828.00M(+744.9%)
$2.45B(+2.1%)
Dec 1993
$2.40B(+22.6%)
$98.00M(-88.1%)
$2.40B(+18.0%)
Sep 1993
-
$823.00M(+16.9%)
$2.04B(+0.7%)
Jun 1993
-
$704.00M(-9.5%)
$2.02B(+1.8%)
Mar 1993
-
$778.00M(-390.3%)
$1.99B(+1.4%)
Dec 1992
$1.96B(-29.1%)
-$268.00M(-133.2%)
$1.96B(-30.3%)
Sep 1992
-
$808.00M(+20.8%)
$2.81B(+0.9%)
Jun 1992
-
$669.00M(-10.9%)
$2.79B(-0.9%)
Mar 1992
-
$751.00M(+28.8%)
$2.81B(+1.7%)
Dec 1991
$2.77B(+15.8%)
$583.00M(-25.6%)
$2.77B(+4.2%)
Sep 1991
-
$784.00M(+12.8%)
$2.65B(+2.6%)
Jun 1991
-
$695.00M(-1.3%)
$2.59B(+3.6%)
Mar 1991
-
$704.00M(+49.2%)
$2.50B(+4.6%)
Dec 1990
$2.39B(+120.6%)
$472.00M(-34.1%)
$2.39B(-162.4%)
Sep 1990
-
$716.00M(+18.2%)
-$3.83B(+72.1%)
Jun 1990
-
$606.00M(+1.8%)
-$2.23B(+279.0%)
Mar 1990
-
$595.00M(-110.4%)
-$587.00M(-154.2%)
Dec 1989
$1.08B(-38.8%)
-$5.75B(-347.7%)
$1.08B(-50.4%)
Sep 1989
-
$2.32B(+3.4%)
$2.19B(+6.0%)
Jun 1989
-
$2.24B(-0.9%)
$2.06B(+7.5%)
Mar 1989
-
$2.27B(-148.8%)
$1.92B(+8.4%)
Dec 1988
$1.77B(+20.7%)
-$4.64B(-311.5%)
$1.77B(-20.0%)
Sep 1988
-
$2.20B(+4.5%)
$2.21B(+16.1%)
Jun 1988
-
$2.10B(-0.8%)
$1.91B(+12.5%)
Mar 1988
-
$2.12B(-150.4%)
$1.69B(+15.5%)
Dec 1987
$1.47B
-$4.20B(-322.4%)
$1.47B(-74.1%)
Sep 1987
-
$1.89B(0.0%)
$5.67B(+50.0%)
Jun 1987
-
$1.89B(0.0%)
$3.78B(+100.0%)
Mar 1987
-
$1.89B
$1.89B

FAQ

  • What is Bristol-Myers Squibb annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual EBIT year-on-year change?
  • What is Bristol-Myers Squibb quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly EBIT year-on-year change?
  • What is Bristol-Myers Squibb TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM EBIT year-on-year change?

What is Bristol-Myers Squibb annual earnings before interest & taxes?

The current annual EBIT of BMY is -$6.43B

What is the all time high annual EBIT for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual earnings before interest & taxes is $9.61B

What is Bristol-Myers Squibb annual EBIT year-on-year change?

Over the past year, BMY annual earnings before interest & taxes has changed by -$16.04B (-166.96%)

What is Bristol-Myers Squibb quarterly earnings before interest & taxes?

The current quarterly EBIT of BMY is $3.46B

What is the all time high quarterly EBIT for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly earnings before interest & taxes is $3.46B

What is Bristol-Myers Squibb quarterly EBIT year-on-year change?

Over the past year, BMY quarterly earnings before interest & taxes has changed by +$14.56B (+131.24%)

What is Bristol-Myers Squibb TTM earnings before interest & taxes?

The current TTM EBIT of BMY is $8.12B

What is the all time high TTM EBIT for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM earnings before interest & taxes is $9.99B

What is Bristol-Myers Squibb TTM EBIT year-on-year change?

Over the past year, BMY TTM earnings before interest & taxes has changed by +$12.67B (+278.82%)
On this page